OBJECTIVE: In a prospective two-phase intervention study we evaluated a newly developed computerised pharmacy decision support system (PDSS) for the counselling of patients with allergic rhinitis and conjunctivitis. METHOD: Community pharmacists were invited to counsel a virtual patient in a first interview. Immediately thereafter, we trained pharmacists to operate the PDSS, which they applied in a second patient interview immediately following the training. We assessed the completeness of mandatory questions asked as defined by national guidelines. RESULTS: Participating pharmacists (n = 50, 78% female, mean age 34 [IQR: 27-40] years, 8 [2-14.5] years of practical experience, 32% specialised in community pharmacy) asked considerably more mandatory questions to confirm appropriateness of self-medication with 7 (5.25-9; 78%) from 9 questions compared to 2 (1-3; 22%) without PDSS (median; P < 0.001). In particular, using the PDSS more than doubled mandatory questions (9/12, 6.25-10; 75% vs. 4/12, 3-5; 33%; P < 0.001) relevant for appropriate drug selection. CONCLUSION: Pharmacists omitted many questions mandatory to assess whether self-medication is appropriate. Using the newly developed PDSS more than doubled the number of mandatory questions asked. The results suggest that the PDSS is ready for evaluation of its impact in real patients.
OBJECTIVE: In a prospective two-phase intervention study we evaluated a newly developed computerised pharmacy decision support system (PDSS) for the counselling of patients with allergic rhinitis and conjunctivitis. METHOD: Community pharmacists were invited to counsel a virtual patient in a first interview. Immediately thereafter, we trained pharmacists to operate the PDSS, which they applied in a second patient interview immediately following the training. We assessed the completeness of mandatory questions asked as defined by national guidelines. RESULTS: Participating pharmacists (n = 50, 78% female, mean age 34 [IQR: 27-40] years, 8 [2-14.5] years of practical experience, 32% specialised in community pharmacy) asked considerably more mandatory questions to confirm appropriateness of self-medication with 7 (5.25-9; 78%) from 9 questions compared to 2 (1-3; 22%) without PDSS (median; P < 0.001). In particular, using the PDSS more than doubled mandatory questions (9/12, 6.25-10; 75% vs. 4/12, 3-5; 33%; P < 0.001) relevant for appropriate drug selection. CONCLUSION: Pharmacists omitted many questions mandatory to assess whether self-medication is appropriate. Using the newly developed PDSS more than doubled the number of mandatory questions asked. The results suggest that the PDSS is ready for evaluation of its impact in real patients.
Authors: Lisa E Hines; Kim R Saverno; Terri L Warholak; Ann Taylor; Amy J Grizzle; John E Murphy; Daniel C Malone Journal: Res Social Adm Pharm Date: 2011-05-06
Authors: A Schroeder; R Kumar; J A Pongracic; C L Sullivan; D M Caruso; J Costello; K E Meyer; Y Vucic; R Gupta; J S Kim; R Fuleihan; X Wang Journal: Clin Exp Allergy Date: 2009-02 Impact factor: 5.018
Authors: Abdelrahman G Tawfik; Abdullah I Abdelaziz; Mohamad Omran; Khaled A Rabie; Al-Shaimaa F Ahmed; Adel Abou-Ali Journal: Int J Clin Pharm Date: 2020-11-24
Authors: Stephanie Dramburg; María Marchante Fernández; Ekaterina Potapova; Paolo Maria Matricardi Journal: Front Immunol Date: 2020-09-10 Impact factor: 7.561